Hi,
In EU MDR, Annex XIV-Clinical Evaluation Plan says, "a specification of methods to be used for examination of qualitative and quantitative aspects of clinical safety with clear reference to the determination of residual risks and side-effects"
What do these methods mean?
TIA!
In EU MDR, Annex XIV-Clinical Evaluation Plan says, "a specification of methods to be used for examination of qualitative and quantitative aspects of clinical safety with clear reference to the determination of residual risks and side-effects"
What do these methods mean?
TIA!